Huaiqihuang Granule in the Treatment of Primary Glomerulonephritis of Stage CKD3

Recruiting

Phase 4 — The treatment has already been approved. Researchers are tracking how it works in a large number of people over time.

Trial locations(34 sites)

China

Beijing Hospital, Beijing, Beijing Municipality

Lanzhou University Second Hospital, Lanzhou, Gansu

The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi

The Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei

The First Affiliated Hospital of Hebei North University, Zhangjiakou, Hebei